Brent crude futures edged up 12 cents to $67.16 a barrel at 0041 GMT. U.S. West Texas Intermediate crude was trading up 13 cents at $65.42, after hitting its highest since April 4 earlier in the ...

A six-fold jump in corporate tax revenue since 2014 to 28 billion euros last year, or 29% of all tax collected - even before an extra 11 billion euros of Apple (NASDAQ: AAPL) back taxes is included - ...

The revised proposal, unveiled by USTR on Friday, would remove LNG-related penalties for failing to export a percentage of fuel on U.S.-owned ships. It also would reduce fees when foreign-built car ...

It was a fairly quiet start to the week across global markets on Monday, with strong equity gains in Asia followed by a grind higher on Wall Street which lifted the MSCI World index to a fresh record ...

Investing.com -- Block Inc’s Square (NYSE: XYZ) has unveiled its new artificial intelligence tool, Square AI, which is ...

The company’s stock movement reflects market reaction to the potential increase in debt and the implications of the convertible notes on shareholder value. The financial maneuvers, including the ...

Cracker Barrel aims to use the net proceeds from this offering for general corporate purposes, which may include redeeming or repaying existing indebtedness, such as the 0.625% convertible senior ...

The citrus grower posted a loss of -$0.17 per share for the quarter ended April 30, missing the analyst estimate of $0.04 profit. Revenue came in at $35.1 million, well below the consensus forecast of ...

Investing.com -- President Donald Trump took a more neutral tone toward Tesla (NASDAQ: TSLA) CEO Elon Musk in a press ...

“Payment resumption may pressure other delinquencies, as student borrowers are more likely to miss payments on other debt.

The global video gaming industry is entering a new era of pricing power, platform shifts, and AI-driven innovation, with Bernstein forecasting a return to growth in 2025 after a turbulent year.

Avidity Biosciences, based in San Diego, reported that it has confirmed with the FDA that the accelerated approval pathway is open for its investigational therapy, del-brax. This therapy is designed ...